Pregled bibliografske jedinice broj: 742099
How pharmacoeconomics should be applied to support decisions in lower income European countries?
How pharmacoeconomics should be applied to support decisions in lower income European countries? // Abstract Book, First Macedonian and Fourth Adriatic Congress on Pharmacoeconomics and Outcomes Research / Suturkova, Ljubica ; Vitezić, Dinko (ur.).
Ohrid, Sjeverna Makedonija, 2014. str. 11-11 (pozvano predavanje, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 742099 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
How pharmacoeconomics should be applied to support decisions in lower income European countries?
Autori
Kalo, Zoltan ; Vitezić, Dinko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Abstract Book, First Macedonian and Fourth Adriatic Congress on Pharmacoeconomics and Outcomes Research
/ Suturkova, Ljubica ; Vitezić, Dinko - , 2014, 11-11
Skup
First Macedonian and Fourth Adriatic Congress on Pharmacoeconomics and Outcomes Research
Mjesto i datum
Ohrid, Sjeverna Makedonija, 24.04.2014. - 27.04.2014
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
health care resources; reimbursement; new medicines; cost-effectiveness; pharmacoeconomic analyses
Sažetak
As health care resources are limited all over the world, reimbursement and formulary listing of new medicines is subject to their cost-effectiveness and affordability in more and more countries. The need for pharmacoeconomic evidence fundamentally changes the algorithm of coverage decisions, therefore medical professionals and policymakers have to be familiar with the principles of pharmacoeconomics, including advantages and limitations of different approaches to estimate the health benefit, cost-effectiveness and budget impact of medicines and the transferability of results among countries. Synthesis of scientific evidence provides better understanding of stakeholders on the real value of innovative medical technologies. The value proposition of health technologies are illustrated by different case studies in the workshop. In lower income European countries the major bottleneck of implementation evidence based health policy are the lack of trained health economists and local data for the adaptation of international economic models. The workshop provides practical guidance for the collection of local data in pharmacoeconomic analyses.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
062-0620063-0060 - Uporaba kardiovaskularnih lijekova i značaj farmakoekonomskih procjena (Vitezić, Dinko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka
Profili:
Dinko Vitezić
(autor)